Click here for prescribing information.

Braltus is licensed as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease.1

Watch this short animation to learn about:

  • Braltus
  • the Zonda inhaler
  • potential cost savings for the NHS.

Further information
Click here to watch a video on how to use the Braltus® Zonda® inhaler

Reference

  1. Teva UK Limited. Tiotropium (Braltus) 10mcg inhalation powder—summary of product characteristics. June 2016. Available at: www.medicines.org.uk/emc/medicine/32634

Approval code: UK/BRA/17/0009d

Date of preparation: June 2017